Kasabach-Merritt syndrome (KMS) is a consumptive coagulopathy associated with the presence of a large vascular lesion. It is often a frustrating condition to treat and it carries a high mortality rate. There are currently no known treatment guidelines. Kasabach-Merritt syndrome is associated with kaposiform hemangioendothelioma (KHE) and tufted angioma (TA); these lesions, when associated with KMS, are locally invasive, aggressive vascular tumors. Treatment options include supportive care, local therapies, and drug and surgical management. In most recent case reports, a multimodal approach to therapy is taken.
Objective and Conclusion:
The objective of this article is to provide a comprehensive review of KMS and give an up-to-date summary of treatment options. The clinical presentation, laboratory findings, vascular pathology, and pathophysiology will also be discussed.
Get full access to this article
View all access options for this article.
References
1.
HosomoSOhnoT. Successful transcutaneous embolization of a giant hemangioma associated with high output cardiac failure and Kasabach–Merritt syndrome: A case report. J Perinat Med1999; 27(5):399–403.
2.
BowersREGrahamEATomlinsonKM. The natural history of the strawberry nevus. Arch Dermatol960; (82):667–680. EzekowitzRAMullikenJBFolkmanJ. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med1992; 326(22):1456–1463.
3.
KasabachHHMerrittKK. Capillary hemangioma with extensive purpura. Am J Dis Child1940; 59:1063–1070.
4.
ShimWKT. Hemangiomas of infancy complicated by thrombocytopenia. Am J Surg1968; 116:896–906.
5.
SarkarMMullikenJB. Thrombocytopenic coagulopathy (Kasabacli–Merritt phenomenon) is associated with kaposiform hemangioendothelioma and not with common infantile hemangioma. Plast Reconstr Surg1997; 100(6):1377–1386.
6.
MaguinessSMMooreGPDoyleJJ. Nine patients with Kasabach–Merritt syndrome: A retrospective review. Blood2000; 96(11):4053 [abstract].
Abvarez-MendozaALourdesTS. Histopathology of vascular lesions found in Kasabach–Merritt syndrome: Review based on 13 cases. Pediatr Dev Pathol. 2000; 3(6):556–560.
9.
HuBLachmanR. Kasabach–Merritt syndrome associated with kaposiform hemangioendothelioma successfully treated with cyclophophamide, vincristine and actinomycin D. J Pediatr Hematol Oncol1998; 20(6):567–569.
10.
BleiFKarpNRofsyN. Successful multimodal therapy for kaposiform hemangioendothelioma complicated by Kasabach–Merritt Phenomenon: Case report and, review of the literature. Pediatr Hematol Oncol1998;15(4):295–305.
11.
SzlachetkaDM. Kasabach-Merritt syndrome: A case review. Neonatal Network1998;17(1):7–15.
12.
Leate-LabrezeCBioulac-Sage. Tufted angioma associated with platelet trapping syndrome, response to aspirin. Arch Dermatol1997; 133:1077–1079.
13.
MentzelT. Hemangioendotheliomas—evolution of a concept of a heterogenous group of vascular neoplasms. Verh Dtsch Ges Pathol1998; 82:99–111.
14.
EsterlyNB. Kasabach–Merritt syndrome in infants. J Am Acad Dermatol1983; 8:504–513.
15.
VerheulHMPanigrahyD. Treatment of Kasabach–Merritt syndrome with pegylated recombinant human megakaryocyte growth factor in mice: Elevated platelet counts, prolonged survival and tumour growth inhibition. Pediatr Res1999; 46(5):562–565
16.
KrafchikB. Vascular lesions in children. Can J Dermatol1989; l(4):71–76.
17.
PhillipsWGMardsenJR. Kasabach–Merritt syndrome exacerbated by platelet transfusion. J R Soc Med1993; 86:231–232
18.
FriedenIJ. Which hemangiomas to treat and how. Arch Dermatol1997; 133:1593–1595.
19.
SadanNWolachB. Treatment of hemangiomas of infants with high doses of prednisone. J Pediatr1996; 128:141–146.
OrtelTBOnoratoJJ. Antifibrinolytic therapy in the management of Kasabach–Merritt syndrome. Am J Hematol1988; 29:44–48.
22.
TamayoLOrtizDM. Therapeutic efficacy of interferon Alfa-2b in infants with life-threatening giant hemangiomas1997; 133:1567–1577.
23.
BarlowCFPriebeCJMullikenJB. Spastic diplegia as a complication of interferon alfa-2a treatment of Hemangiomas of Infancy. J Pediatr, 1998; 132:527–530.
24.
de ProstYTeillacD. Successful treatment of Kasabach–Merritt syndrome with pentoxyphylline. J Am Acad Dermatol. 1991; 25(5):854–855.
25.
YangYHLePI. Absolute ethanol embalotherapy for hemangioma with Kasabach–Merritt syndrome. Chung Hua Min Kua1998; 39(1):51–54.
26.
MitsuhashiNFurataM. Outcome of radiation therapy for patients with Kasabach–Merritt syndrome. Int J Radiat Oncol Biol Phys1997; 39(2):467–473.
27.
EnjolrasO. Vascular tumors and vascular malformations: Are we at the dawn of a better knowledge?Pediatr Dermatol1999; 16(3);238–241.
